Skip to main content
Clinical Trials/ISRCTN81508784
ISRCTN81508784CompletedNot Applicable

Botulinum toxin in the treatment of orofacial tardive dyskinesias: a single blind study

Parnassia Psycho-medical Centre (Netherlands)0 sites14 target enrollmentStarted: March 8, 2006Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
14

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Patients suffering from orofacial tardive dyskinesias for at least 3 months
  • 2. Stable dosage of psychopharmacological medication
  • 3. Written informed consent by the patient

Exclusion Criteria

  • 1. Age younger than 18 years
  • 2. Contraindication for botulinum toxin (myasthenia gravis, Lambert Eaton Myasthenic Syndrome)
  • 3. Women known to be pregnant or having a positive pregnancy test

Investigators

Sponsor
Parnassia Psycho-medical Centre (Netherlands)

Similar Trials